Isabel Cuella-Martin

7PUBLICATIONS
79CO-AUTHORS
VirologyMedical microbiology not elsewhere classifiedMedical bacteriologyInnate immunityCentral and Eastern European languages (incl. Russian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2025
Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.

Bertin C Bisimwa, Maja Kiselinova, Isabel Cuella-Martin

|Mar 22, 2025
Paucibacillary Tuberculosis Drives the Low Positive Predictive Value of Xpert MTB/RIF Ultra for Rifampicin Resistance Detection in Low-Prevalence Settings.

Isabel Cuella-Martin, Francois Hakizayezu, Aymen Ahmed

|Mar 03, 2025
Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.

I Cuella-Martin, D Runyambo, S De Bock

|Aug 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site.

Tom G Caniels, Max Medina-Ramìrez, Shiyu Zhang

|Jul 25, 2024
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.

Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza

|Aug 04, 2022
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.

Mathieu Claireaux, Tom G Caniels, Marlon de Gast

Pageof 2

Frequent Collaborators

3 joint publications

Marit J van Gils

3 joint publications

Tom G Caniels

3 joint publications

Rogier W Sanders

2 joint publications

Jonathan L Torres